Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diclonile Cream
- Development stage
- Unknown
- Lead developer
- Nilegenix
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Diclonile Cream is a topical small molecule analgesic and anti-inflammatory medication marketed by Nilegenix, a generic pharmaceutical company based in Sangli, India. It is indicated for the relief of muscle pain and joint pain. Although the specific active ingredients are not explicitly detailed in the company's commercial listing, the name is indicative of diclofenac, a nonsteroidal anti-inflammatory drug (NSAID). The product is an approved generic formulation intended for local application to reduce inflammation and pain at the site of musculoskeletal injury or condition.
- Brand names
- Diclonile Cream
- Other names
- Diclonile
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Diclonile Cream.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Diclonile Cream.